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The cholecystokinin (CCK) receptor in purified plasma membranes prepared from mouse pancreatic acini 
had a binding affinity of 1.8 nM, an acid pH optimum between 6.0 and 6.5, and an analog specificity of 
CCKs > CCK33 > desulphated CCKs > CC&. Binding of CCK to its receptor was abolished by 
pretreatment of plasma membranes with trypsin. When [ “‘I]CCK was cross-linked to its receptors with 
disuccinimidyl suberate, and the preparation solubilized and subjected to gel electrophoresis and 
autoradiography, the hormone was associated with iW80000 protein in both the presence and absence of 
the reducing agent dithiothreitol. 
Cholectystokinin 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Cholecystokinin (CCK) is the major hormonal 
regulator of pancreatic acinar cell function [I ,2]. 
Employing the biologically active ligand, [ 12’I]BH- 
CCK33, we have demonstrated the presence of 
specific receptors for CCK both in intact pancreatic 
acini [3] and on particulate fractions prepared 
from the whole pancreas [4]. However the nature 
and location of the CCK receptor is unknown. 
Recent autoradiographic studies suggest the plasma 
membrane as the major site for the binding of 
radioiodinated CCK to pancreatic acini [5]. Accor- 
dingly, we prepared purified plasma membranes 
from mouse pancreatic acini and measured the 
characteristics of CCK binding to this subcellular 
organelle. Moreover, we utilized the bifunctional 
cross-linker, disuccinimidyl suberate, to determine 
the size and subunit structure of the CCK receptor. 
2.1. Preparation of pancreatic plasma membranes 
Male Swiss Webster mice (25 g) were fasted 18 h 
before study. Isolated pancreatic acini were pre- 
pared according as in [6]. Plasma membranes were 
then prepared as in [7] and stored at -80°C. The 
protein concentration of the membrane was deter- 
mined using a Coomassie Blue (Bio-Rad) protein 
assay reagent [8]. 
2.2. Binding of (1251/BwCCK to pancreatic 
plasma membrane 
Pure natural porcine cholecystokinin (CCK33) 
was iodinated to specific activities of 200-300 
&i/,ug by conjugation with N-succinimidyl-3-(4- 
hydroxy,5-[‘251]-iodophenyl) propionate ([1251]- 
BH-reagent) as in [9]. Pancreatic plasma mem- 
branes, at 15 pg protein/ml, were incubated with 
50 pM [‘251]BH-CCK in HEPES buffer at pH 7.4 
[4] and enriched with 5 mg/ml bovine serum 
albumin, 1 mg/ml bacitracin and 0.2 mg/ml soy- 
bean trypsin inhibitor. To determine non-specific 
binding, CCKE at 100 nM was added. Samples * To whom correspondence should be addressed 
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were incubated at 24°C and then centrifuged at 
10000 x g for 1 min. The binding supernatants 
were used to determine the degradation of 
[ lz51] BH-CCK with trichloroacetic acid added at a 
final concentration of 10% [3]. 
The dissociation of [ ‘251]BH-CCK from the 
membrane protein was studied under two condi- 
tions: 
(i) by a loo-times dilution of the hormone-recep- 
tor complex [lo]; 
(ii) by dilution to the same extent in a medium 
containing an excess of unlabeled hormone 
(100 nM CCKs). 
After incubation at 24°C the diluted membranes 
were collected by filtration through cellulose ace- 
tate membrane filters (Oxoid, 0.45 pm pore size). 
2.3. Affinity cross-linking of CCK receptors 
Affinity cross-linking was performed by in- 
cubating membranes (at 0.05 mg protein/ml in 
HEPES-buffered solution (pH 6.5) with 1 nM 
[1251]BH-CCK for 30 min at 24°C. After incuba- 
tion, membranes were washed, and resuspended in 
phosphate-buffered saline at pH 7.4 and then incu- 
bated with 5 mM disuccinimidyl suberate for 
15 min at 4°C. The cross-linking reaction was 
quenched by addition of excess 10 mM Tris 
(pH 7.4) with 1 mM EDTA at 4°C. Finally, the 
cross-linked materials were pelleted at 25000 x g 
for 20 min, resuspended in 62.5 mM Tris, 2.3% 
sodium dodecyl sulfate, and 10% glycerol, at 
pH 6.8. Electrophoresis was carried out using 
7.5% acrylamide in the presence or absence of 
50 mM dithiothreitol. Dried gels were exposed to 
Kodak X-omat AR film for 4 weeks. 
3. RESULTS 
3.1. Characterization of CCK binding to plasma 
membrane receptors 
The binding of 50 pM [1251]BH-CCK was rapid 
with binding occurring after 30 min (fig.1). Non- 
specific binding was negligible. Degradation of 
CCK was linear throughout the incubation, but 
was <lo% after 60 min. When [‘251]BH-CCK was 
bound to plasma membranes for 30 min and then 
the reaction mixture diluted lOO-fold, the labeled 
CCK dissociated with a one-half time of 60 min 
(fig.1). The addition of excess unlabeled CCKs 
after dilution greatly accelerated the dissociation 
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Fig. 1. Time curse of [“‘I] BH-CCK binding, degradation 
and dissociation in pancreatic plasma membranes. Top: 
degradation; Middle: total binding (o), and non-specific 
binding (0); Bottom: dissociation by dilution only (0), 
and dissociation by dilution plus unlabeled CCKs (0). 
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Fig. 2. Analog specificity of [1251]BH-CCK-binding to 
pancreatic plasma membranes. 
of the radiolabeled CCK, suggesting the presence 
of negative cooperative interactions. 
Scatchard analysis of binding of [ 1251] BH-CCK 
at steady state revealed a single order of binding 
sites with Kd of 1.83 f 0.29 nM (mean + SE, n = 4). 
Total binding capacity was 22.9 f 4.5 pmol/mg 
protein. CCK analog studies revealed a potency of 
CCKs > CCK33 > desulfated CCKg > CC& as 
defined by their ability to compete with [1251]BH- 
CCK for the pancreatic CCK receptor (fig.2). 
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To study whether the plasma membrane CCK re- 
ceptor was a protein, we incubated the plasma 
membranes with 0.1 mg trypsin/ml followed by an 
excess of trypsin inhibitor. This treatment reduced 
CCK binding by ~95%. 
3.2. Covalent cross-linking of “‘I-BH-CCK to its 
receptors 
To cross-link CCK to its receptors, plasma mem- 
branes were first incubated with 1 nM [“‘I]BH- 
CCK for 30 min, washed, and then treated with 
A BCO 
Fig. 3. Autoradiogram of a SDS polyacrylamide gel of 
pancreatic plasma membranes cross-linked to [“‘I] BH- 
CCK with disuccinimidyl suberate. (A) [‘2511BH-CCK; 
(B) [‘*‘I]BH-CCK + dithiothreitol; (C) [‘*‘I]BH-CCK + 
unlabeled CCKs; (D) [‘*‘I]BH-CCK + unlabeled CCKs + 
To study the nature of this protein [‘251]BH- 
CCK was cross-linked to its receptor with disucci- 
nimidyl suberate, a procedure previously used to 
study the nature of the receptor for inslin and other 
peptide hormones [12]. These data suggested that 
the receptor was a single protein with a i%& of 
80000. Studies with the reducing agent dithiothrei- 
to1 also suggested that the CCK receptor was not a 
polymer connected by sulphydryl bonds. The size 
of this receptor is thus similar to the receptors for 
glucagon [ 131, prolactin [ 141, and gonadotropin 
[ 151, but smaller than those for insulin, EGF and 
IGF [12,16,17]. In [18] it was reported that cross- 
linking of [‘251]BH-CCK to rat pancreatic plasma 
membranes labels an M, 85000 protein. 
dithiothreitol. We find that purified pancreatic acinar plasma 
5 mM disuccinimidyl suberate; this concentration 
of cross-linker was found to give optimal results. 
Autoradiographs of SDS gels revealed that a major 
band of radioactivity was present at M, of 80000. 
Several minor bands were present which may have 
represented partially degraded receptor. The ap- 
pearance of both major and minor bands were 
totally eliminated by the presence of 100 nM CCKs 
during the [ 1z51] BH-CCK binding period. Virtually 
the same patterns were observed when 50 mM 
dithiothreitol was added to the solubilization 
solution. 
4. DISCUSSION 
These studies demonstrate the existence of speci- 
fic binding sites for [ ‘251]BH-CCK on purified 
mouse pancreatic acinar plasma membranes. This 
binding was time-dependent, reversible, inhibited 
by CCK analogs in proportion to their known bio- 
logical activities, and it showed evidence for nega- 
tive cooperative effects [ 10,111. These binding 
characteristics are identical to those observed with 
both isolated pancreatic acini and particulate frac- 
tions prepared from whole pancreas. 
Scatchard analysis showed a single order of 
binding sites with an affinity constant similar to 
that seen for pancreatic particles 141. In contrast, 
the number of binding sites/unit protein was 
200-times greater in plasma membranes, a finding 
that is consistent with the concept that the major 
site of binding of CCK in the pancreas is to the 
plasma membrane. Furthermore, studies with tryp- 
sin indicated that the CCK receptor is a protein. 
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membranes have a large number of receptor sites 
for CCK. The receptor is protein in nature and has 
an app. M, of 80000. Therefore, these data agree 
with observations uggesting that the initial step in 
the action of CCK is binding to a specific receptor 
localized on the plasma membrane of pancreatic 
acinar cells [2]. 
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